A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants
Clinical trial NCT03822767 · COMPLETED
Trial details
- NCT number
- NCT03822767
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2018-09-20
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.